Related Experiment Video
Updated: Jul 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Mutations of TGFbeta signaling molecules in human disease
Kelly A Harradine1, Rosemary J Akhurst
1Cancer Research Institute, Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA.
Abstract:
The transforming growth factor beta (TGFbeta) signaling pathway regulates several biological processes including cellular proliferation, differentiation, apoptosis, migration, and extracellular matrix deposition. Ligand and receptor family members signal through two main Smad signaling branches, TGFbeta/activin to Smad2/3 (Sma and MAD-related proteins) and bone morphogenetic protein (BMP) to Smad1/5. At the molecular level, TGFbeta acts by modifying cytoskeletal organization and ultimately regulating expression of specific target genes. Germline disruption of TGFbeta signaling leads to several types of hereditary congenital malformation or dysfunction of the skeletal, muscular and/or cardiovascular systems, and to cancer predisposition syndromes. In this review, the molecular etiology of TGFbeta-associated disorders is examined, together with a discussion of clinical overlap between syndromes and possible biological explanations underlying the variable penetrance and expressivity of clinical characteristics. Increasing our understanding of the molecular etiology underlying genotype-phenotype correlations will ultimately provide a molecular-based approach that should result in better prognostic tools, smart therapeutics and individualized disease management, not only for these rare syndromes, but for more generalized disorders of the cardiovascular and musculoskeletal systems and cancer. The clinical consequence of TGFbeta signaling mutations appears to depend on environmental factors and on the basal levels of ongoing signaling transduction networks specific to each individual. In this respect, genetic background might be a central factor in determining disease outcome and treatment strategy for TGFbeta-associated diseases.
Insights
Transforming growth factor beta (TGFbeta) signaling impacts cell functions and development. Mutations in TGFbeta signaling cause congenital disorders and cancer, with outcomes influenced by genetics and environment.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- The transforming growth factor beta (TGFbeta) signaling pathway is crucial for regulating cellular proliferation, differentiation, apoptosis, migration, and extracellular matrix deposition.
- TGFbeta signaling involves two main Smad branches: TGFbeta/activin to Smad2/3 and bone morphogenetic protein (BMP) to Smad1/5, ultimately modifying cytoskeletal organization and gene expression.
Purpose of the Study:
- To review the molecular etiology of TGFbeta-associated disorders.
- To discuss clinical overlap between syndromes and explain variable penetrance and expressivity.
- To explore how understanding genotype-phenotype correlations can improve diagnostics and therapeutics for TGFbeta-related diseases.
Main Methods:
- Literature review of molecular mechanisms and clinical manifestations of TGFbeta signaling pathway disruptions.
- Analysis of genotype-phenotype correlations in hereditary congenital malformations, dysfunctions, and cancer predisposition syndromes.
- Examination of factors influencing disease outcome, including environmental influences and genetic background.
Main Results:
- Germline disruption of TGFbeta signaling is linked to skeletal, muscular, and cardiovascular system defects, as well as cancer predisposition.
- Clinical presentation of TGFbeta-associated disorders shows significant variability, influenced by environmental factors and individual genetic makeup.
- Understanding the molecular basis of TGFbeta signaling is key to developing better prognostic tools and personalized treatment strategies.
Conclusions:
- TGFbeta signaling pathway mutations underlie a spectrum of congenital disorders and cancers.
- Variable expressivity and penetrance in these disorders are modulated by genetic background and environmental factors.
- Further research into TGFbeta signaling mechanisms will facilitate individualized disease management and therapeutic development for related conditions.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
General Transcription Factors
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway
Inflammatory Bowel Disease III: Crohn's Disease
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...

